| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/12/2005 | CA2542875A1 Method and antisense composition for selective inhibition of hiv infection in hematopoietic cells |
| 05/12/2005 | CA2542861A1 Methods for treating non-microbial inflammatory skin conditions |
| 05/12/2005 | CA2542839A1 The use of ifenprodril in the treatment of pain |
| 05/12/2005 | CA2542837A1 The use of non-opiates for the potentiation of opiates |
| 05/12/2005 | CA2542836A1 Pharmaceutical formulations containing quetiapine |
| 05/12/2005 | CA2542776A1 Nucleoside compounds for treating viral infections |
| 05/12/2005 | CA2542752A1 Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof |
| 05/12/2005 | CA2542537A1 Process for producing injectable gabapentin compositions |
| 05/12/2005 | CA2542536A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain |
| 05/12/2005 | CA2542530A1 Pharmaceutical aerosol compositions |
| 05/12/2005 | CA2542277A1 Method for the treatment or prevention of respiratory inflammation with a cyclooxygenase-2 inhibitor in combination with a phosphodiesterase 4 inhibitor and compositions therewith |
| 05/12/2005 | CA2542047A1 Hydroxy pyridopyrrolopyrazine dione compounds useful as hiv integrase inhibitors |
| 05/12/2005 | CA2541852A1 Bone morphogenetic protein (bmp) 2a and uses thereof |
| 05/12/2005 | CA2541629A1 Methods and compositions comprising ilex |
| 05/12/2005 | CA2540949A1 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 05/12/2005 | CA2540881A1 Thieno-pyridinone derivatives as kinase inhibitors |
| 05/12/2005 | CA2540686A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist |
| 05/12/2005 | CA2540460A1 Heterocyclic compounds and methods of making and using thereof |
| 05/12/2005 | CA2540342A1 4-amino (aza) quinoline derivatives as capsaicin receptor agonists |
| 05/12/2005 | CA2539817A1 Tocopheryl polyethylene glycol succinate articles and process for preparing tpgs articles |
| 05/12/2005 | CA2539446A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 05/12/2005 | CA2539335A1 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis |
| 05/12/2005 | CA2537059A1 Anhydrous silver dihydrogen citrate compositions |
| 05/12/2005 | CA2527495A1 High molecular weight polymers, devices and method for making and using same |
| 05/11/2005 | EP1529784A1 Polymeric anhydride of magnesium and proteic ammonium phospholinoleate-palmitoleate. |
| 05/11/2005 | EP1529777A2 Process and oxazolidine intermediate for the synthesis of taxanes |
| 05/11/2005 | EP1529532A1 Antiallergic composition comprising stachyose |
| 05/11/2005 | EP1529530A1 Compounds affecting glucokinase |
| 05/11/2005 | EP1529529A1 Medicament containing an effector of the glutathione metabolism together with $g(a)-lipoic acid for immunomodulation, immunostimulation and/or antiphlogistic treatment |
| 05/11/2005 | EP1529528A1 2-pyrrolidone derivatives and their use in protecting mammalian cells against oxidation stress |
| 05/11/2005 | EP1529527A2 Valproic acid for a combination treatment of human cancers, tumor metastasis and minimal residual disease |
| 05/11/2005 | EP1529526A1 Sustained-release pharmaceutical compositon |
| 05/11/2005 | EP1529525A1 ENOS transcription enhancers for use in the cell therapy of ischemic heart diseases |
| 05/11/2005 | EP1529524A1 Softgelatine capsule comprising fat-soluble vitamins and essential fatty acids |
| 05/11/2005 | EP1529522A1 Peeling composition comprising vitamin B3 and vitamin C |
| 05/11/2005 | EP1529520A1 Use of licochalcone A or a licochalcone A containing extract from Radix Glycyrrhizae inflatae against postinflammatory hyperpigmentation |
| 05/11/2005 | EP1529116A1 Methods for the treatment of dementia based on apo e genotype |
| 05/11/2005 | EP1529062A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 05/11/2005 | EP1529058A2 A non-selective cation channel in neural cells and methods for treating brain swelling |
| 05/11/2005 | EP1529054A2 Therapeutic protein and treatments |
| 05/11/2005 | EP1529053A2 Macrolide compounds endowed with antiinflammatory activity |
| 05/11/2005 | EP1529050A1 Cephalosporins |
| 05/11/2005 | EP1529049A2 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 05/11/2005 | EP1529048A2 Methods for the synthesis of substituted purines |
| 05/11/2005 | EP1529047A2 New purine derivatives |
| 05/11/2005 | EP1529046A1 Substituted benzimidazole compounds |
| 05/11/2005 | EP1529045A2 New compounds |
| 05/11/2005 | EP1529043A1 Novel process |
| 05/11/2005 | EP1529042A1 Arylamides |
| 05/11/2005 | EP1529041A1 NOVEL PRODRUGS OF 1-METHYL-2(4-AMIDINOPHENYLAMINOMETHYL)-BENZIMIDAZOL-5-YL-CARBOXYLIC ACID-( i N /i -2-PYRIDIL- i N /i -2-HYDROXYCARBONYLETHYL)-AMIDE, PRODUCTION AND USE THEREOF AS MEDICAMENTS |
| 05/11/2005 | EP1529038A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/11/2005 | EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof |
| 05/11/2005 | EP1529032A1 Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2,6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile |
| 05/11/2005 | EP1529031A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 05/11/2005 | EP1529030A2 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 05/11/2005 | EP1529025A1 Polyisoprenylbenzophenone derivatives, method for production and use thereof |
| 05/11/2005 | EP1528931A1 Methods for improving islet signaling in diabetes mellitus and for its prevention |
| 05/11/2005 | EP1528927A1 Use of carboxamides for the treatment of tinnitus |
| 05/11/2005 | EP1528926A1 Novel pharmaceutical composition of ceftiofur |
| 05/11/2005 | EP1528925A1 Quinazoline derivatives for use in the treatment of cancer |
| 05/11/2005 | EP1528924A1 Mch1r antagonists |
| 05/11/2005 | EP1528923A1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris |
| 05/11/2005 | EP1528922A1 Use of treosulfan and derivatives thereof for treating multiple sclerosis |
| 05/11/2005 | EP1528921A2 Methods for treatment and prevention of gastrointestinal conditions |
| 05/11/2005 | EP1528920A1 Method for suppressing proliferation of abnormal prion protein with leucine, isoleucine or valine |
| 05/11/2005 | EP1528919A2 Therapeutic use of aryl amino acid derivatives |
| 05/11/2005 | EP1528917A2 Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release |
| 05/11/2005 | EP1528913A1 Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating |
| 05/11/2005 | EP1528894A2 Biomatrix structural containment and fixation systems and methods of use thereof |
| 05/11/2005 | EP1528863A1 Cereal based food product comprising dha and/or epa |
| 05/11/2005 | EP1458391A4 A method of treating bacterial infections using gemifloxacin or a salt thereof and a beta-lactam antibiotic |
| 05/11/2005 | EP1417172A4 Process for the preparation of amorphous form of torsemide |
| 05/11/2005 | EP1399127B1 Olopatadine formulations for topical administration |
| 05/11/2005 | EP1397363B1 5-ethyl-imidazotriazinones |
| 05/11/2005 | EP1370245B1 Method to prepare microparticles containing metoprolol |
| 05/11/2005 | EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 05/11/2005 | EP1337532B1 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 05/11/2005 | EP1309563B1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 05/11/2005 | EP1289522B1 Medicaments for the adjuvant therapy of dementia comprising alpha lipoic acid |
| 05/11/2005 | EP1286590A4 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or beta-sheet rich pathological precursor thereof |
| 05/11/2005 | EP1280531A4 Local anesthetic methods and kits |
| 05/11/2005 | EP1257526B1 Aniline-derived ligands for the thyroid receptor |
| 05/11/2005 | EP1254138B1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 05/11/2005 | EP1230549B1 Method for solubilising optical markers |
| 05/11/2005 | EP1221952B1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 05/11/2005 | EP1177790B1 Therapy with cannabinoids in the treatment of cerebral tumor |
| 05/11/2005 | EP1165541B1 Dimeric compounds and as inhibitors of neuraminidase |
| 05/11/2005 | EP1156791B1 Bupropion to treat viral diseases |
| 05/11/2005 | EP1154777B1 Medicament for treating hypertension |
| 05/11/2005 | EP1147087B1 Phenanthridine-n-oxides with pde-iv inhibiting activity |
| 05/11/2005 | EP1128829B1 Riluzole and alpha-tocopherol combination |
| 05/11/2005 | EP1100771B1 Compounds and compositions for delivering active agents |
| 05/11/2005 | EP1084711B1 Remedies for the treatment of itching containing pgd2 antagonists |
| 05/11/2005 | EP1083931B1 Stabilization of compositions containing ace inhibitors using magnesium oxide |
| 05/11/2005 | EP1066269B1 Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections |
| 05/11/2005 | EP1063992B1 Sulfurpenta fluorophenyl pyrazoles for controlling ectoparasitic infestations |
| 05/11/2005 | EP1059930B1 Compositions comprising isovaleramide and ibuprofen |
| 05/11/2005 | EP1057485B1 Potassium channel activators |
| 05/11/2005 | EP1019072B1 Method for assisting in differential diagnosis and treatment of autistic syndromes |
| 05/11/2005 | EP1005337B1 Pharmacologic drug combination in vagal-induced asystole |